Anaesthesia in patients with cystic fibrosis

Giorgio Della Rocca1

  • 1Istituto di Anestesiologia e Rianimazione, University of Rome 'La Sapienza', Rome, Italy. giorgio.dellarocca@uniroma1.it

Insights

Cystic fibrosis (CF) patients require specialized surgical care due to respiratory complications. Anesthesia is safe for minor surgeries in CF patients, with careful preoperative preparation crucial for minimizing risks.

Area of Science:

  • Medical Genetics
  • Pulmonology
  • Anesthesiology

Background:

  • Cystic fibrosis (CF) is an autosomal-recessive genetic disorder affecting multiple organs, primarily the lungs.
  • CF affects approximately 1 in 2000 children, with a majority now surviving into adulthood.
  • The increasing lifespan of CF patients leads to a higher prevalence of surgical interventions.

Purpose of the Study:

  • To review the anesthetic considerations for patients with cystic fibrosis undergoing surgery.
  • To highlight the importance of preoperative assessment and perioperative care in managing CF patients.
  • To discuss the implications of advanced treatments like lung transplantation for CF anesthesia.

Main Methods:

  • Review of preoperative assessment protocols for cystic fibrosis patients.
  • Emphasis on strategies for optimal clearance of respiratory secretions.
  • Discussion of pre-, intra-, and postoperative management plans, including physiotherapy and medical therapies.

Main Results:

  • Anesthesia for minor surgical procedures in CF patients can be performed safely with a low incidence of postoperative respiratory complications.
  • Comprehensive preoperative preparation, including physiotherapy and targeted medical treatments, is essential.
  • Lung transplantation has significantly improved outcomes for end-stage CF patients, presenting unique anesthetic challenges.

Conclusions:

  • Careful planning and management are critical for successful surgical outcomes in cystic fibrosis patients.
  • Anesthesiologists play a vital role in optimizing care and minimizing risks for this patient population.
  • Advances in treatment, including transplantation, offer improved prognoses but require specialized anesthetic approaches.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.